Hydrogel–Nanolipid Formulations for the Complex Anti-Inflammatory and Antimicrobial Therapy of Periodontitis
Pharmaceutics · 07.05.2025 · 17 (5) · 620
DOI: 10.3390/pharmaceutics17050620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.05.2025. Verfasst von Rabia Ashfaq und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Culture and Innovation of Hungary, Hungarian Academy of Sciences, the University Research Scholarship Program (EKÖP).
Abstract (Originalsprache)
Objectives
This study aimed to develop and evaluate nanostructured lipid carriers (NLCs) loaded with meloxicam (Melox) and a therapeutic antibacterial and anti-inflammatory liquid lipid, clove oil (CO) for periodontitis treatment, a complex inflammatory condition necessitating advanced drug delivery systems. The NLC–Melox formulation was integrated into three hydrogels, hypromellose (HPMC), zinc hyaluronate (ZnHA), and sodium hyaluronate (NaHA), to conduct a comparative analysis focusing on enhanced localized drug delivery, improved mucoadhesion, prolonged retention, and significant therapeutic outcomes.
Methods
NLC–Melox was prepared by homogenization and characterized by dynamic light scattering (DLS). Subsequently, NLC–Melox-loaded gels were subjected to transmission electron microscopy (TEM), differential scanning calorimetry (DSC), X-ray diffraction (XRD), Raman spectroscopy, and rheological analysis. In vitro drug release, anti-inflammatory activity (BSA denaturation assay), and antibacterial efficacy (MIC, MBC) were investigated to assess therapeutic potential.
Results
DLS revealed a particle size of 183 nm with a polydispersity index of 0.26, indicating homogeneity. TEM confirmed consistent morphology and uniform nanoparticle distribution. DSC and XRD demonstrated the amorphous nature of Melox, enhancing solubility and stability. Spectroscopy confirmed no chemical interactions between components. Rheological studies identified ZnHA as the most mucoadhesive and structurally stable gel. In vitro release studies showed sustained drug release over 24 h. Melox and CO-loaded formulations demonstrated significant anti-inflammatory activity and notable antibacterial efficacy due to the antibacterial oil.
Conclusions
The study highlighted the potential of NLC-based mucoadhesive hydrogels as an effective strategy for periodontitis treatment. The formulation offered improved drug solubility, therapeutic efficacy, mucoadhesivity, and prolonged delivery, making it a promising candidate for localized therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, H-6720 Szeged, Hungary.
- Core Facility, HUN-REN Biological Research Centre, H-6726 Szeged, Hungary.
- Theoretical Medicine Doctoral School, University of Szeged, H-6722 Szeged, Hungary.
- Department of Medical Microbiology, University of Szeged, H-6720 Szeged, Hungary.
ORCID-Profile: Anita Kovács, Szilvia Berkó, Gábor Katona, Rita Ambrus, Tamás Ferenc Polgár, Katalin Burián, Mária Budai-Szűcs
Förderung
- Ministry of Culture and Innovation of Hungary
- Hungarian Academy of Sciences
- the University Research Scholarship Program (EKÖP)
- The University of Szeged Open Access Fund
- Ministry of Culture and Innovation of Hungary from the National Research, Development, and Innovation Fund
- János Bolyai Research Scholarship of the Hungarian Academy of Sciences
- Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund
Zitieren
APA
Ashfaq, R., Tóth, N., Kovács, A., Berkó, S., Katona, G., Ambrus, R., Polgár, T. F., Szécsényi, M., Burián, K., & Budai-Szűcs, M. (2025). Hydrogel–Nanolipid Formulations for the Complex Anti-Inflammatory and Antimicrobial Therapy of Periodontitis. Pharmaceutics, 17(5), 620. https://doi.org/10.3390/pharmaceutics17050620
Vancouver
Ashfaq R, Tóth N, Kovács A, Berkó S, Katona G, Ambrus R, et al. Hydrogel–Nanolipid Formulations for the Complex Anti-Inflammatory and Antimicrobial Therapy of Periodontitis. Pharmaceutics. 2025;17(5):620. doi:10.3390/pharmaceutics17050620
BibTeX
@article{Ashfaq2025,
author = {Ashfaq, Rabia and Tóth, Nóra and Kovács, Anita and Berkó, Szilvia and Katona, Gábor and Ambrus, Rita and Polgár, Tamás Ferenc and Szécsényi, Mária and Burián, Katalin and Budai-Szűcs, Mária},
title = {Hydrogel–Nanolipid Formulations for the Complex Anti-Inflammatory and Antimicrobial Therapy of Periodontitis},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {5},
pages = {620},
doi = {10.3390/pharmaceutics17050620}
}
EUVIMED